Top Markets
Coin of the day
A-SPINE Asia Co., Ltd. A-SPINE Asia Co., Ltd.

A-SPINE Asia Co., Ltd.

6758
Rank in Stocks #31662
A-SPINE Asia Co., Ltd. functions as a medical device enterprise, specializing... A-SPINE Asia Co., Ltd. functions as a medical device enterprise, specializing in the entire cycle of research, development, production, and worldwide distribution of spinal implants and surgical instruments. The company's market presence spans numerous countries, including Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. Their product catalog features a variety of spinal stabilization systems, such as solutions for cervical anterior fixation, alongside thoracic and lumbar fixation devices. Additionally, A-SPINE Asia provides a comprehensive range of interbody fusion systems, encompassing ACDF, PLIF, TLIF, and ALIF cages. Its offerings further extend to balloon kyphoplasty and vertebral body replacement devices. Beyond its own manufactured products, the firm also acts as a distributor for a selection of imported orthopedic medical equipment. Established in 2001, A-SPINE Asia Co., Ltd. is based in New Taipei City, Taiwan.
Share Price
$0.92535171
Last synced: 2026-08-17
Market Cap
$12.47M
Change (1 day)
0.00%
Change (1 year)
-33.83%
Country
TW
Trade A-SPINE Asia Co., Ltd. (6758)

Category

Revenue for A-SPINE Asia Co., Ltd. (6758)
Revenue in Aug 2026 TTM: 0
According to A-SPINE Asia Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for A-SPINE Asia Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US